🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Background: Gleich syndrome is also called episodic angioedema with eosino...
Status
Terminated
Location
National Institutes of Health Clinical Center
Start Date
2021-01-14
Trial ID
NCT04128371
Treatments Being Tested
Mepolizumab is a humanized monoclonal antibody. In conditions where eosinop...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-03-07
Trial ID
NCT02836496
Mepolizumab is a humanized Immunoglobulin G1 (IgG1) monoclonal antibody (mA...
Status
Terminated
Location
GSK Investigational Site
Start Date
2017-03-21
Trial ID
NCT03055195
Treatments Being Tested
Eosinophilic Granulomatosis with Polyangiitis (EGPA), also referred to as C...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-04-14
Trial ID
NCT03298061
Treatments Being Tested
Mepolizumab (SB-240563) is a humanized monoclonal antibody (Immunoglobulin ...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-01-06
Trial ID
NCT03014674
Treatments Being Tested
Mepolizumab, a humanized monoclonal antibody, has been developed as an add-...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-08-29
Trial ID
NCT03562195
Treatments Being Tested
Mepolizumab is a humanized monoclonal antibody (IgG1, kappa) that blocks in...
Status
Completed
Location
GSK Investigational Site
Start Date
2021-06-29
Trial ID
NCT04276233
Treatments Being Tested
The purpose of this randomized, double-blind study is to investigate the ef...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-02-05
Trial ID
NCT02020889
Treatments Being Tested